ClinConnect ClinConnect Logo
Search / Trial NCT03619356

Investigation of Hemoglobin Oxygenation With Third Harmonic Generation Microscopy

Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Aug 1, 2018

Trial Information

Current as of November 11, 2025

Enrolling by invitation

Keywords

Hemoglobin Oxygenation Concentration Tumor Diabetes

ClinConnect Summary

This is an observational research study that tests a new imaging method called spectrally resolved third-harmonic generation (srTHG) microscopy to measure oxygen levels and other properties of human red blood cells. Researchers at National Taiwan University Hospital in Taipei want to see if analyzing light signals from blood can quantify oxygenation and provide clues about tumor-related biology, with the goal of helping understand early disease processes. It does not involve testing a drug or implant.

Who can join? Adults aged 20 and older who are healthy volunteers. The study plans to enroll about 100 people, and participants are invited rather than recruited openly. If you participate, you can expect to contribute blood samples and undergo srTHG imaging and related analyses, with study activities spanning up to about two years. This study is not regulated by the FDA for drugs or devices. Location is National Taiwan University Hospital in Taipei.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • older than 20 years old
  • Exclusion Criteria:
  • Vulnerable groups, such as pregnant women, prisoners, students, mentally handicapped, aborigines, etc.

About National Taiwan University Hospital

National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.

Locations

Taipei, Taiwan

Taipei, Taiwan

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials